Loading clinical trials...

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01770951

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.

Lead sponsor: Alexion Pharmaceuticals, Inc.•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more

COMPLETEDPhase 2

The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT01757431 · Atypical Hemolytic Uremic Syndrome (aHUS)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 18, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment30

Start dateAug 2009

Last updatedAug 18, 2023

Condition

Atypical Hemolytic Uremic Syndrome (aHUS)

Locations shown

Dunwoody, Georgia

Chicago, Illinois

Portland, Maine

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 18, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions